Lundbeck acquires Longboard Pharmaceuticals for $2.6B to strengthen neuroscience pipeline.
Lundbeck has announced its acquisition of Longboard Pharmaceuticals for about $2.6 billion. This strategic move aims to significantly strengthen Lundbeck's neuroscience pipeline, enhancing its position in the pharmaceutical industry.
October 14, 2024
23 Articles